"Extracellular Matrix Protection Factor-1, a Novel Human Osteoarthritis Therapeutic, Decreases the Expression of Interleukin-1 Beta by Primary Cultures of Human Osteoarthritic Chondrocytes" by Firas Alsaid

Presentation

Extracellular Matrix Protection Factor-1, a Novel Human Osteoarthritis Therapeutic, Decreases the Expression of Interleukin-1 Beta by Primary Cultures of Human Osteoarthritic Chondrocytes

The FASEB Journal (2018)

Firas Alsaid, Bio‐Medical SciencesPCOMPhiladelphiaPA
Dimitry Belogorodsky, Bio‐Medical SciencesPCOMPhiladelphiaPA
Andrea Lynn Healy, Orthopedic SurgeryCooper University HospitalCamdenNJ
LaBraya Milton, Orthopedic SurgeryCooper University HospitalCamdenNJ
Hannah Ruth Popper, Bio‐Medical SciencesPCOMPhiladelphiaPA
Patrisia Mattioli, Bio‐Medical SciencesPCOMPhiladelphiaPA
Lawrence Miller, Orthopedic SurgeryCooper University HospitalCamdenNJ
Kathryn Behling, Biomedical SciencesCooper School of Medicine of Rowan UniversityCamdenNJ
Abdulhafez Selim, Bio‐Medical SciencesPCOMPhiladelphiaPA
Marina D'Angelo, PhD, Bio‐Medical SciencesPCOMPhiladelphiaPA

Link

Disciplines

Oncology

Publication Date

April 1, 2018

DOI

10.1096/FASEBJ.2018.32.1_SUPPLEMENT.640.3

Citation Information

Firas Alsaid, Dimitry Belogorodsky, Andrea Lynn Healy, LaBraya Milton, et al.. "Extracellular Matrix Protection Factor-1, a Novel Human Osteoarthritis Therapeutic, Decreases the Expression of Interleukin-1 Beta by Primary Cultures of Human Osteoarthritic Chondrocytes" The FASEB Journal Vol. 32 (2018)
Available at: http://works.bepress.com/marina_dangelo/56/